Viveve Medical Inc. (NASDAQ:VIVE) Latest News, Stock Price and Trading Information

Viveve Reports Preliminary Full Year 2018 Financial Results, Announces 2019 Revenue Guidance and Provides Corporate Update

Globe Newswire 16-Jan 8:28 AM

Viveve Completes Enrollment in LIBERATE-International Trial for Improvement of Stress Urinary Incontinence

Globe Newswire 3-Jan 8:28 AM

Viveve Announces FDA Clearance to Advance VIVEVE II Clinical Study to Full Enrollment

Globe Newswire 20-Dec 4:50 PM

Viveve Announces Closing of Public Offering of Shares of Common Stock

Globe Newswire 11-Dec 4:05 PM

Viveve Announces Pricing of Public Offering of Shares of Common Stock

Globe Newswire 6-Dec 9:49 PM

Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study

Globe Newswire 6-Dec 4:03 PM

Viveve Announces Proposed Public Offering of Shares of Common Stock

Globe Newswire 6-Dec 4:01 PM

Viveve to Host Stress Urinary Incontinence Symposium with Physician Opinion Leaders

Globe Newswire 29-Nov 8:28 AM

New Research Coverage Highlights Chuy's, Viveve Medical, ClearSign Combustion, WhiteHorse Finance, Crinetics Pharmaceuticals, and Boston Omaha Consolidated Revenues, Company Growth, and Expectations for 2018

Globe Newswire 21-Nov 8:20 AM